This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Trump Tariff Shakes U.S. Market: 5 Inverse ETFs to Gain
by Sweta Killa
The U.S. equity index nosedived on Trump's sweeping series of tariffs, resulting in a spike for inverse or inverse-leveraged ETFs.
Inverse ETFs to Play Now on Middle East Tension & Rising Rates?
by Sanghamitra Saha
Wall Street wavered this week on high inflation data which lowered chances of an imminent Fed rate cut. Plus, geopolitical tension in Middle East has weighed on stocks.
5 Best Inverse-Leveraged ETFs of February
by Sweta Killa
Wall Street gave a dismal performance last month on Fed's longer-than-expected rate hike speculation, with all three major indices in red.
6 Best Inverse/Leveraged ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was downbeat last week, with losses seen in all major indexes.
5 Inverse ETFs to Tap Worsening Russia-Ukraine Tension
by Sweta Killa
Investors are betting that the recent pain in the stock market will intensify and are thus loading up ETFs against the market surge.
4 Inverse leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street crashed last week on renewed virus fear, election uncertainty and subdued tech earnings.
5 High-Flying Leveraged or Inverse ETFs From a Rough October
by Sweta Killa
We have highlighted some leveraged/inverse ETFs from different corners that piled up substantial gains in October though these involve a great deal of risk when compared to traditional products.
Play These ETF Strategies as Dow Posts Worst Q1 on Record
by Sweta Jaiswal, FRM
We highlight some ETF strategies that investors can follow for a smooth sail during the turbulent times.
ETFs to Play as Dow Heads to Worst Month Since Great Depression
by Sweta Jaiswal, FRM
The stock-market rout due to the coronavirus pandemic continues. In such a scenario, the Dow Jones is believed to be nose diving to its worst month since 1931.
ETFs to the Rescue as Coronavirus Fears Beat US Stimulus Flows
by Sweta Jaiswal, FRM
The coronavirus-led bloodbath in major U.S. indices continues despite supportive measures being taken by the government and the central bank.